Presentation NY Valves 2024 A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial Presenter: Ole De Backer June 05, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk February 06, 2019
Presentation The Structural Heart Disease Summit 2018 NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk Presenter: Lars Sondergaard June 21, 2018
Presentation EuroPCR 2018 Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk Presenter: Lars Sondergaard May 25, 2018
Presentation TCT 2017 The NOTION 2 Low-risk Trial in Younger Patients Presenter: Lars Sondergaard October 30, 2017
Presentation TCT 2016 Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard October 30, 2016